Systematic review: pharmacological treatment of tic disorders--efficacy of antipsychotic and alpha-2 adrenergic agonist agents. - Wikidata - wikimedia - TriplyDB

Systematic review: pharmacological treatment of tic disorders--efficacy of antipsychotic and alpha-2 adrenergic agonist agents.

Systematic review: pharmacological treatment of tic disorders--efficacy of antipsychotic and alpha-2 adrenergic agonist agents.

http://www.wikidata.org/entity/Q36906661

about

Antiepileptic drugs for Tourette's syndrome Recent Advances in Understanding and Managing Tourette Syndrome Tics in the Pediatric Population: Pragmatic Management New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity A Review and Update on Tourette Syndrome: Where Is the Field Headed?Practitioner Review: Treatments for Tourette syndrome in children and young people - a systematic review.Living with tics: reduced impairment and improved quality of life for youth with chronic tic disorders The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.Changing patterns of alpha agonist medication use in children and adolescents 2009-2011 Bothersome tics in patients with chronic tic disorders: Characteristics and individualized treatment response to behavior therapy.Assessment and management of treatment-refractory obsessive-compulsive disorder in children.Behavior Therapy for Tic Disorders: An Evidenced-based Review and New Directions for Treatment Research.Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe.Further evidence of behavioral interventions for tic disorders: A reply to Theule and colleagues Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome The Efficacy and Tolerability of the Clonidine Transdermal Patch in the Treatment for Children with Tic Disorders: A Prospective, Open, Single-Group, Self-Controlled Study.Moderators and predictors of response to behavior therapy for tics in Tourette syndrome.Commentary: Are alpha-2 agonist really effective in children with tics with comorbid ADHD? A commentary on Whittington et al. (2016).Aripiprazole-associated tic in a schizophrenia patient.Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part I-Psychiatric and Behavioral Interventions.Serial pharmacological prescribing practices for tic management in Tourette syndrome.Adolescent with tourette syndrome and bipolar disorder: a case report.Lessons Learned from Open-label Deep Brain Stimulation for Tourette Syndrome: Eight Cases over 7 Years.Behavior Therapy for Youth With Tourette Disorder.Aripiprazole versus risperidone for treating children and adolescents with tic disorder: a randomized double blind clinical trial.Neurocognitive correlates of treatment response in children with Tourette's Disorder.Tourette and tic disorders in ICD-11: standing at the diagnostic crossroads.Pharmacotherapies to tics: a systematic review.The Effect of Fecal Microbiota Transplantation on a Child with Tourette Syndrome.

P2860

Q24186745-1193AD44-FA0D-439D-9787-8D2D07E0AE9D Q26766090-E09E44C5-031A-4BD9-ADD9-676FDE0D272F Q33577672-394412C5-33A2-473E-B681-D3FB1D29101D Q33961196-2B17C179-706F-406E-B4DB-1A6C0BE3A86C Q34516696-77DB53D8-ACA3-43A8-A226-9A934FC9EFF2 Q34524415-909940BD-4C1C-4883-AA5D-3004ACA86850 Q35040183-FEBF7281-4114-417A-A925-7006AB7FF9B9 Q35208541-09D6A788-57AE-4AA4-A708-8BC52E26609B Q35641630-552359BC-C9B8-4E7A-B785-9CEFD84449CA Q35667681-5AE80568-A8A2-45F8-8928-3669047A407F Q35697831-1A9C0DEA-BC48-440A-8146-5EA7065AC8D6 Q36239182-54FB5AA5-C613-46D6-AC82-FD9D87DA0B43 Q36446854-11321221-0A98-463B-AB4B-6A0E0790D056 Q36553551-242E7057-6E59-439E-A219-3F4FB0004783 Q37246827-212E9F6F-4383-4955-B1C9-016180518BEC Q37660848-2A4AEA17-72A0-497E-B8D7-D3F2C7A4199E Q38380736-75B7C296-FE34-4F22-BF6D-62DD3912CBE7 Q38930475-69FF9227-1BF9-44DE-BC95-22A7A0655BA6 Q39285740-6BEFAC9A-BD04-413E-ABD3-85AD72E78C50 Q40128672-F3F02DDF-BDCA-43B2-8681-33B4CB3ECF6F Q40615771-934231FD-14B7-4A09-9EB7-AA3B7C2E0BD0 Q41938580-44FA1441-22F2-4555-9A9B-C0531015D4A2 Q41942576-2B644CAD-2F2F-4E25-BDAD-D4B74FE548D9 Q46820620-A2A16411-3300-47A7-80B6-783862431504 Q48114550-F54BF4D1-FE15-41FE-92A1-23E747CBE7DA Q50173680-D4F5F171-5238-404F-B069-5059499D4D06 Q50613472-E916C864-5ECF-47A4-8A22-2D8A3D3D05BB Q55365792-0B6FFF7D-F72F-4776-9906-6BEA47D97268 Q55470623-356035E9-58CE-4299-80EA-ACB57CF09B53

P2860

Systematic review: pharmacological treatment of tic disorders--efficacy of antipsychotic and alpha-2 adrenergic agonist agents.

http://www.wikidata.org/entity/Q36906661

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Systematic review: pharmacolog ...... a-2 adrenergic agonist agents.

@en

type

label

Systematic review: pharmacolog ...... a-2 adrenergic agonist agents.

@en

prefLabel

Systematic review: pharmacolog ...... a-2 adrenergic agonist agents.

@en

P1433

Q36906661-7924DB96-D9B8-4070-B635-E83A580D6DC2

P1476

Q36906661-0AE82AE2-BD50-43F3-B687-2393861F23C6

P2093

Q36906661-8064F691-C804-4485-BDAA-B2C893FA9FF7

Q36906661-9209C02A-D170-47FC-BFB9-C70D460D6026

Q36906661-A0C79798-A041-4921-AD1D-34772139FC2B

Q36906661-FA2D6E44-991A-4561-9F36-1991ADDE88FD

P2860

Q36906661-019E78EA-52D4-46B5-A870-C78B3C0EA326

Q36906661-0379F640-35EE-42E5-8429-91352C3C2AE9

Q36906661-04F172AE-89ED-44F8-9A4D-7C9E39BECA9A

Q36906661-0DCBBE79-1226-43FF-9F2E-07611E724C28

Q36906661-125F4A1D-3BE4-4F3F-9293-6DD64C314AF6

Q36906661-1495467A-9FC9-4A7E-8F5A-96F9D5FFAFBC

Q36906661-154AD2B6-39AD-42FE-844D-6CDCDCA61F19

Q36906661-1AB25D0C-F2DF-43E5-9B57-4410B603A885

Q36906661-1CB03A51-6CF4-433C-8946-6CC58A65AFD9

Q36906661-27A3DE0A-5E95-40A2-AD04-DB3820493382

P304

Q36906661-2377E828-8726-4D31-93CE-8031BB59AA83

P31

Q36906661-EBEAB881-6FA7-4254-8E9B-6B6C0F9AA92E

P356

Q36906661-04C35F71-CE92-48E4-B80F-B93446653748

P433

Q36906661-F14E6A61-91B5-49E5-8A90-F99EB0EC26BD

P478

Q36906661-0A274C9C-DF80-494A-A026-BE95D6588A26

P50

Q36906661-6117356A-E99D-4A75-A440-0D9B7D9E35D5

P577

Q36906661-4B2CE9A4-73F5-4BB6-BAC7-5E1873E34786

P698

Q36906661-E75BE6A1-6B77-4FD3-8B54-C0291127F09C

P932

Q36906661-2AE00BB0-741A-41BA-BBAE-170B230C8BF4

P356

J.NEUBIOREV.2012.09.008

P1433

Neuroscience & Biobehavioral Reviews

P1476

Systematic review: pharmacolog ...... a-2 adrenergic agonist agents.

@en

P2093

Hannah Weisman

http://www.w3.org/2001/XMLSchema#string

Imraan A Qureshi

http://www.w3.org/2001/XMLSchema#string

James F Leckman

http://www.w3.org/2001/XMLSchema#string

Michael H Bloch

http://www.w3.org/2001/XMLSchema#string

P2860

Pimozide for tics in Tourette's syndrome

Contemporary assessment and pharmacotherapy of Tourette syndrome

The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder

Functional disturbances within frontostriatal circuits across multiple childhood psychopathologies

Bias in meta-analysis detected by a simple, graphical test

Treatment of ADHD in children with tics: a randomized controlled trial

Tourette syndrome and tic disorders: a decade of progress

Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome

European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment

Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study.

P304

1162-1171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUBIOREV.2012.09.008

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Lawrence Scahill

P577

2012-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23099282

http://www.w3.org/2001/XMLSchema#string

P932

3674207

http://www.w3.org/2001/XMLSchema#string